Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study

Authors: Josef S Smolen, Aileen L. Pangan, Paul Emery, William F. C. Rigby, Yoshiya Tanaka, Juan Ignacio Vargas, Ying Zhang, Nemanja Damjanov, Alan Friedman, Mohamed I. A. Othman, Heidi S. Camp, Stanley Cohen - The Lancet 2019 cited by 378